IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

ABSTRACT: A open label 1:1 randomized phase II exploratory study investigating adjuvant therapy in patients with molecular biologically detectable residual disease after primary resection for localized colorectal tumors.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Circulating Tumor Dna,Adjuvant Chemotherapy,Progression Free Survival

PROVIDER: 2290096 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR